The ubiquitin-activating enzyme, UBA1, as a novel therapeutic target for AML
Oncotarget
.
2018 Sep 28;9(76):34198-34199.
doi: 10.18632/oncotarget.26153.
Authors
Samir H Barghout
1
,
Aaron D Schimmer
1
Affiliation
1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
PMID:
30344936
PMCID:
PMC6188141
DOI:
10.18632/oncotarget.26153
No abstract available
Keywords:
AML; MLN7243; TAK-243; UBA1; Ubiquitin.
Publication types
Editorial